{
    "title": "Breast cancer drug shown to reduce recurrence risk",
    "url": "https://www.dailymail.co.uk/wires/afp/article-12152361/Breast-cancer-drug-shown-reduce-recurrence-risk.html",
    "date": "2023-06-02",
    "keywords": [
        "cancer",
        "breast",
        "ribociclib",
        "group",
        "trial",
        "stage",
        "percent",
        "recurrence",
        "study",
        "therapy",
        "treatment",
        "statement",
        "patient",
        "disease",
        "novartis",
        "risk",
        "slamon",
        "hormone",
        "survival",
        "need",
        "cell",
        "mammography",
        "paolicalmette",
        "institute",
        "france",
        "prospect",
        "drug",
        "maker",
        "quarter",
        "earlystage",
        "friday",
        "society",
        "oncologys",
        "meeting",
        "class",
        "asco",
        "expert",
        "nanda",
        "research",
        "majority",
        "standard",
        "chemotherapy",
        "radiation",
        "blockade",
        "author",
        "dennis",
        "jonsson",
        "center",
        "iii",
        "diagnosis",
        "persistent",
        "worry",
        "president",
        "coalition",
        "committee",
        "ii",
        "subtype",
        "brand",
        "name",
        "kisqali",
        "half",
        "period",
        "difference",
        "reduction",
        "recurrencefree",
        "diseasefree",
        "press",
        "world",
        "benefit",
        "lymph",
        "population",
        "healthcare",
        "rate",
        "side",
        "type",
        "blood",
        "pain",
        "cdk4",
        "cdk6",
        "division",
        "data",
        "end",
        "year"
    ],
    "category": [
        "wires",
        "afp"
    ]
}